Servier India introduces ‘Ivosidenib’(Tibsovo®), in India, First-in-class Targeted Therapy in Oncology for Rare IDH1-Mutated AML and Cholangiocarcinoma

Marks an important development in oncology, providing a treatment option for patients with AML and cholangiocarcinoma in India. Announced during AML Awareness month, highlighting Servier India’s ongoing efforts to support patients with rare and difficult-to-treat cancers   Mumbai, India, June 05, 2025 – Servier India, a subsidiary of the leading French pharmaceutical Servier Group, today announced …

IHub-Data, IIIT Hyderabad Announces Workshop on IoT-AI for Healthcare Innovation

Hyderabad, India – IHub-Data, IIIT Hyderabad, is organizing a three-day hands-on workshop titled “IoT-AI for Healthcare”, scheduled from June 23 to 25, 2025. This immersive short-term course aims to bridge the gap between healthcare and cutting-edge technology by equipping students with practical skills in integrating Internet of Things (IoT) and Artificial Intelligence (AI) for real-world healthcare …